RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
III. Medizinische Klinik – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 27 pages - $500
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 42 pages - $500
Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 51 pages - $500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
MND Diagnostic LTD - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
Trophos SA - Product Pipeline Review - Q4 2010
Nov 2010 - 37 pages - $500
King III and IT Outsourcing in South Africa
Apr 2011 - 22 pages - $1,895
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Therapeutic target
Other therapeutic del
Development phase
Phase III/IV del

Browse By

Industry sector
Antibody-based diagnostics
Biomarker-based diagnostics
CAT
Genetic diagnostics
Imaging
MRI
Nuclear medicine
Other
Self-test systems
Supplies
Test systems
Ultrasound
X-ray
Therapeutic target
Ayuverdic medicine
Chinese medicine
Dietetic
Homeopathy
Iron excess
Kanpo medicine
Other

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us